Alan Lockley joins as Director of Global Services, Edward Quinn as Director of Product Development and Mark Appleton takes new role as Director of Research London, UK — H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimisation, safety, and scale-up, today announced three key appointments to the Company’s senior leadership […]

Large multi-site COVID-19 study to use IsoPlexis Single Cell Functional Proteomics to survey immunity. BRANFORD, Conn. — IsoPlexis (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a partnership with MediMergent, LLC, and The Center for Cancer and Blood Disorders (CCBD), an American Oncology Partners of […]

Singulator™ 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. LIVERMORE, Calif. — S2 Genomics, Inc. today announced that it has entered into a distribution agreement with Techtum Lab AB for the promotion, sales, and support of S2 Genomics’ Singulator™ 100 System and associated products for single-cell genomics […]

EMERYVILLE, Calif. — SLINGSHOT BIOSCIENCES, INC., the makers of synthetic control cells for cell analysis applications, including flow cytometry, enabling precise, reliable, and repeatable results, today announced they had extended their distribution channel through a new agreement with BIOKÉ, an experienced and knowledgeable company from the Netherlands that provides innovative products with the highest quality in […]

LIVERMORE, Calif.–S2 Genomics, Inc., today announced that it has entered into a distribution agreement with Eisenberg for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in Israel. “Israel is a thriving market for single-cell genomics and cell biology research, creating a need for […]

RoosterBio, Inc., has entered an exclusive distributor partnership with MBL Beijing Biotech. We are thrilled to partner with the MBL Beijing team to accelerate the development of cell and exosome products and help deliver these innovative therapies to patients in China.” — Tim Kelly, CEO of RoosterBio FREDERICK, MARYLAND, UNITED STATES — RoosterBio, Inc., a […]

Utrecht (the Netherlands) — The specialized private equity fund invests in scaling-up production and development of new medical tests Gilde Healthcare, a specialized healthcare investor, today announces its intention to acquire Sanquin Reagents from Sanquin Health Solutions (SHS) with its private equity fund. Sanquin Reagents produces and sells blood group and immune reagents, materials needed […]

Activator Protein 1 (AP-1) Assay Provides Researchers with Insight into Cancer and Inflammation State College, PA  – INDIGO Biosciences announced today the addition of a new cell-based firefly luciferase reporter assay for the Human Activator Protein 1 (AP-1) transcription factor. The new assay augments INDIGO’s existing collection of related transcription factor assays including Human NF-kB and Nuclear Factor of Activated […]

ABEC continues proactive investment to support broad industry adoption of its Custom Single Run (CSR®) single-use biomanufacturing solutions Bethlehem, PA, USA – ABEC, a global provider of engineered solutions and services for biotech manufacturing, today announced it will invest $11 million to expand single-use disposable container (DC) manufacturing capacity for its CSR biomanufacturing solutions. The company’s project in […]

BRANFORD, Conn. — IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced the appointment of Nachum “Homi” Shamir to its Board of Directors as a Class II director. Mr. Shamir was most recently the Chairman and Chief Executive Officer of Luminex […]